Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) EBT Margin (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of EBT Margin data on record, last reported at 3.06% in Q2 2025.

  • For Q2 2025, EBT Margin rose 1580.0% year-over-year to 3.06%; the TTM value through May 2025 reached 30.01%, down 3743.0%, while the annual FY2025 figure was 30.01%, 3743.0% down from the prior year.
  • EBT Margin reached 3.06% in Q2 2025 per LFCR's latest filing, up from 42.04% in the prior quarter.
  • Across five years, EBT Margin topped out at 47.02% in Q4 2023 and bottomed at 118.05% in Q2 2023.
  • Average EBT Margin over 5 years is 23.03%, with a median of 24.15% recorded in 2022.
  • Peak YoY movement for EBT Margin: plummeted -8465bps in 2022, then skyrocketed 9920bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 4.97% in 2021, then tumbled by -947bps to 42.06% in 2022, then skyrocketed by 212bps to 47.02% in 2023, then plummeted by -143bps to 20.05% in 2024, then soared by 85bps to 3.06% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 3.06% in Q2 2025, 42.04% in Q1 2025, and 20.05% in Q4 2024.